PA.6
NCT01526135
PA.6
Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma
Status:
Closed to Accrual
III
Phase
Adjuvant
Line of Therapy
Advanced / Metastatic
Disease Stage
Biomarker(s)
N/A
Investigational
Product
mFOLFIRINOX
Treatment Arms
o Active Comparator: Arm A GEMCITABINE
o Experimental: Arm B mFOLFIRINOX